Count | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 6 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 5 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Brain Neoplasms/complications/radionuclide imaging/secondary | 1 |
Brain Neoplasms/classification/*enzymology/mortality/secondary | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Brain Neoplasms/*drug therapy/mortality/pathology/*secondary | 1 |
Brain Neoplasms/*cerebrospinal fluid/diagnosis/secondary/therapy | 1 |
| 3 | |
| 6 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 4 | |
| 6 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 7 | |
| 3 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |